Historical Valuation
TriSalus Life Sciences Inc (TLSI) is now in the Fair zone, suggesting that its current forward PS ratio of 5.08 is considered Fairly compared with the five-year average of -4.47. The fair price of TriSalus Life Sciences Inc (TLSI) is between 4.40 to 5.80 according to relative valuation methord.
Relative Value
Fair Zone
4.40-5.80
Current Price：5.80
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
TriSalus Life Sciences Inc (TLSI) has a current Price-to-Book (P/B) ratio of -11.39. Compared to its 3-year average P/B ratio of -4.14 , the current P/B ratio is approximately 174.85% higher. Relative to its 5-year average P/B ratio of -2.79, the current P/B ratio is about 308.64% higher. TriSalus Life Sciences Inc (TLSI) has a Forward Free Cash Flow (FCF) yield of approximately -7.27%. Compared to its 3-year average FCF yield of -25.37%, the current FCF yield is approximately -71.34% lower. Relative to its 5-year average FCF yield of -17.86% , the current FCF yield is about -59.29% lower.
P/B
Median3y
-4.14
Median5y
-2.79
FCF Yield
Median3y
-25.37
Median5y
-17.86
Competitors Valuation Multiple
AI Analysis for TLSI
The average P/S ratio for TLSI competitors is 5.48, providing a benchmark for relative valuation. TriSalus Life Sciences Inc Corp (TLSI.O) exhibits a P/S ratio of 5.08, which is -7.33% above the industry average. Given its robust revenue growth of 57.38%, this premium appears sustainable.
Performance Decomposition
AI Analysis for TLSI
1Y
3Y
5Y
Market capitalization of TLSI increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of TLSI in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is TLSI currently overvalued or undervalued?
TriSalus Life Sciences Inc (TLSI) is now in the Fair zone, suggesting that its current forward PS ratio of 5.08 is considered Fairly compared with the five-year average of -4.47. The fair price of TriSalus Life Sciences Inc (TLSI) is between 4.40 to 5.80 according to relative valuation methord.
What is TriSalus Life Sciences Inc (TLSI) fair value?
TLSI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of TriSalus Life Sciences Inc (TLSI) is between 4.40 to 5.80 according to relative valuation methord.
How does TLSI's valuation metrics compare to the industry average?
The average P/S ratio for TLSI's competitors is 5.48, providing a benchmark for relative valuation. TriSalus Life Sciences Inc Corp (TLSI) exhibits a P/S ratio of 5.08, which is -7.33% above the industry average. Given its robust revenue growth of 57.38%, this premium appears sustainable.
What is the current P/B ratio for TriSalus Life Sciences Inc (TLSI) as of Jan 10 2026?
As of Jan 10 2026, TriSalus Life Sciences Inc (TLSI) has a P/B ratio of -11.39. This indicates that the market values TLSI at -11.39 times its book value.
What is the current FCF Yield for TriSalus Life Sciences Inc (TLSI) as of Jan 10 2026?
As of Jan 10 2026, TriSalus Life Sciences Inc (TLSI) has a FCF Yield of -7.27%. This means that for every dollar of TriSalus Life Sciences Inc’s market capitalization, the company generates -7.27 cents in free cash flow.
What is the current Forward P/E ratio for TriSalus Life Sciences Inc (TLSI) as of Jan 10 2026?
As of Jan 10 2026, TriSalus Life Sciences Inc (TLSI) has a Forward P/E ratio of -23.51. This means the market is willing to pay $-23.51 for every dollar of TriSalus Life Sciences Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for TriSalus Life Sciences Inc (TLSI) as of Jan 10 2026?
As of Jan 10 2026, TriSalus Life Sciences Inc (TLSI) has a Forward P/S ratio of 5.08. This means the market is valuing TLSI at $5.08 for every dollar of expected revenue over the next 12 months.